Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma - a report of eight cases

Clinical Oncology

Volumn 23, Issue 10, 2011, Pages 716-718

  Giacchero, D ^a   Barriere J ^b   Benezery, K ^b   Guillot, B ^c   Dutriaux, C ^d   Mortier, L ^e   Lacour, J P ^a   Thyss, A ^b   Peyrade, F ^b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c HÔPITAL SAINT ELOI   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; CELL SURFACE; CLINICAL ARTICLE; DISEASE COURSE; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LETTER; LYMPHADENOPATHY; MALE; METASTASIS; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RASH; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 80055122112     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.07.007     Document Type: Letter

References (8)

1. Maubec E., Duvillard P., Velasco V., Crickx B., Avril M.F. Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 2005, 25(2B):1205-1210.
2. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354(6):567-578.
3. Kim S., Eleff M., Nicolaou N. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck 2011, 33(2):286-288.
4. Arnold A.W., Bruckner-Tuderman L., Zuger C., Itin P.H. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology 2009, 219(1):80-83.
5. Suen J.K., Bressler L., Shord S.S., Warso M., Villano J.L. Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab. Anticancer Drugs 2007, 18(7):827-829.
6. Bauman J.E., Eaton K.D., Martins R.G. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab. Arch Dermatol 2007, 143(7):889-892.
7. Jalili A., Pinc A., Pieczkowski F., Karlhofer F.M., Stingl G., Wagner S.N. Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges 2008, 6(12):1066-1069.
8. Maubec E., Petrow P., Duvillard P., et al. Cetuximab as first-line monotherapy in patients with skin unresectable squamous cell carcinoma: final results of a phase II multicenter study. Oral Session ASCO 2010, abstract #8510. http://meeting.ascopubs.org/cgi/content/abstract/28/15_suppl/8510.